The information on this page has been prepared with reference to published scientific literature, not by a medically qualified expert. It is not medical advice. Any decision to use a supplement or herb-based product is your responsibility. Consult a suitably qualified medical professional, especially if you have underlying conditions. Remember, nothing is for everyone, and not everything sold is what it claims to be. Some things work for some people, some of the time.
Turmeric (Curcuma longa) is a flowering plant of the ginger family (Zingiberaceae), native to the Indian subcontinent and Southeast Asia. The rhizome (underground stem) is used as both a culinary spice and medicinal herb. Turmeric contains compounds called curcuminoids, the most notable being curcumin, which gives turmeric its characteristic yellow color and is responsible for many of its therapeutic effects.
Turmeric should not be confused with Javanese turmeric (Curcuma xanthorrhiza), wild turmeric (Curcuma aromatica), black turmeric (Curcuma caesia), or zedoary (Curcuma zedoaria) - all related species with different phytochemical compositions and potential therapeutic effects. Additionally, "yellow root" may refer to either turmeric or the unrelated plant Hydrastis canadensis (goldenseal), which has entirely different properties.
Image source and license: https://commons.wikimedia.org/wiki/File:Turmeric_flowers.jpg.
Modified by Peter Jorgensen.
It's important to note that while turmeric shows promise for these conditions, it has not been proven to "cure" any disease. The evidence suggests it may help alleviate symptoms or serve as a complementary treatment alongside conventional medical approaches.
The effective dose of turmeric depends significantly on the formulation and the specific condition being treated. Most clinical studies have focused on curcumin rather than whole turmeric, as curcumin is considered the primary active component.
For arthritis, doses of 1,000-1,200 mg of curcumin per day have shown efficacy. For metabolic conditions, 500-2,000 mg daily has been used in studies. The bioavailability of curcumin is notably poor when consumed alone, so many formulations include bioavailability enhancers like piperine or are delivered in liposomal or nanoparticle formulations.
Research on doses exceeding the standard therapeutic range (>2,000 mg of curcumin daily) is limited. Phase I clinical trials have tested doses up to 8,000 mg per day, with dose-limiting toxicity typically being gastrointestinal effects rather than systemic toxicity. No significant additional benefits have been consistently demonstrated at these higher doses, though tolerability varies considerably between different formulations.
A notable knowledge gap exists regarding long-term effects (>1 year) of high-dose curcumin supplementation. Additionally, the efficacy ceiling - the point at which increasing doses no longer provides additional benefits - remains unclear for many conditions and may vary based on the specific outcome measured.
Adibian, M., Hodaei, H., Nikpayam, O., Sohrab, G., Hekmatdoost, A., & Hedayati, M. (2019). The effects of curcumin supplementation on high‐sensitivity C‐reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial. Phytotherapy Research, 33(5), 1374-1383.
Basnet, P., & Skalko-Basnet, N. (2011). Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules, 16(6), 4567-4598.
Daily, J. W., Yang, M., & Park, S. (2016). Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. Journal of medicinal food, 19(8), 717-729.
Jansen van Rensburg, Z. (2022). Identification of components of turmeric as potential therapeutic agents to slow the progression of neurodegeneration in Parkinson’s disease (Doctoral dissertation, Stellenbosch: Stellenbosch University).
Kocaadam, B., & Şanlier, N. (2017). Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Critical reviews in food science and nutrition, 57(13), 2889-2895.
Kumari, A., Raina, N., Wahi, A., Goh, K. W., Sharma, P., Nagpal, R., ... & Gupta, M. (2022). Wound-healing effects of curcumin and its nanoformulations: a comprehensive review. Pharmaceutics, 14(11), 2288.
Kunnumakkara, A. B., Harsha, C., Banik, K., Vikkurthi, R., Sailo, B. L., Bordoloi, D., ... & Aggarwal, B. B. (2019). Is curcumin bioavailability a problem in humans: Lessons from clinical trials. Expert opinion on drug metabolism & toxicology, 15(9), 705-733.
Ng, Q. X., Koh, S. S. H., Chan, H. W., & Ho, C. Y. X. (2017). Clinical use of curcumin in depression: a meta-analysis. Journal of the American Medical Directors Association, 18(6), 503-508.
Pagano, E., Romano, B., Izzo, A. A., & Borrelli, F. (2018). The clinical efficacy of curcumin-containing nutraceuticals: an overview of systematic reviews. Pharmacological research, 134, 79-91.
Razavi, B. M., Ghasemzadeh Rahbardar, M., & Hosseinzadeh, H. (2021). A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytotherapy Research, 35(12), 6489-6513.
Sahebkar, A., Serban, M. C., Ursoniu, S., & Banach, M. (2015). Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Journal of functional foods, 18, 898-909.